These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 12188246)

  • 1. A case report and a proposed algorithm for the transfer of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis to a burn center.
    Ellis MW; Oster CN; Turiansky GW; Blanchard JR
    Mil Med; 2002 Aug; 167(8):701-4. PubMed ID: 12188246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nine years of a single referral center management of Stevens-Johnson syndrome and toxic epidermal necrolysis (Lyell's syndrome).
    Monteiro D; Egipto P; Barbosa J; Horta R; Amarante J; Silva P; Silva A
    Cutan Ocul Toxicol; 2017 Jun; 36(2):163-168. PubMed ID: 27487073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steven Johnson Syndrome and Toxic Epidermal Necrolysis in a burn unit: A 15-year experience.
    McCullough M; Burg M; Lin E; Peng D; Garner W
    Burns; 2017 Feb; 43(1):200-205. PubMed ID: 27554629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatal toxic epidermal necrolysis induced by carbamazepine treatment in a patient who previously had carbamazepine-induced Stevens-Johnson syndrome.
    Huang LY; Liao WC; Chiou CC; Lou JP; Hu P; Ko FC
    J Formos Med Assoc; 2007 Dec; 106(12):1032-7. PubMed ID: 18194909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in Treatment of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis at Burn Centers and Nonburn Centers.
    Nygaard RM; Endorf FW
    J Burn Care Res; 2020 Sep; 41(5):945-950. PubMed ID: 32498082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Burn unit care of Stevens Johnson syndrome/toxic epidermal necrolysis: A survey.
    Le HG; Saeed H; Mantagos IS; Mitchell CM; Goverman J; Chodosh J
    Burns; 2016 Jun; 42(4):830-5. PubMed ID: 26810444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A decade of burn unit experience with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: Clinical pathological diagnosis and risk factor awareness.
    Lim VM; Do A; Berger TG; Nguyen AH; DeWeese J; Malone JD; Jordan K; Hom F; Tuffanelli L; Fillari P; Siu S; Grossman R
    Burns; 2016 Jun; 42(4):836-43. PubMed ID: 26847613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 27 years of a single burn centre experience with Stevens-Johnson syndrome and toxic epidermal necrolysis: analysis of mortality risk for causative agents.
    Weinand C; Xu W; Perbix W; Lefering R; Maegele M; Rathert M; Spilker G
    Burns; 2013 Nov; 39(7):1449-55. PubMed ID: 23702222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stevens-Johnson syndrome and toxic epidermal necrolysis: oncologic considerations.
    Hockett KC
    Clin J Oncol Nurs; 2004 Feb; 8(1):27-30, 55. PubMed ID: 14983759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Examining triage patterns of inhalation injury and toxic epidermal necrolysis-Stevens Johnson syndrome.
    Davis JS; Pandya RK; Pizano LR; Namias N; Dearwater S; Schulman CI
    J Burn Care Res; 2013; 34(5):492-7. PubMed ID: 23966120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of Biobrane
    Rogers AD; Blackport E; Cartotto R
    Burns; 2017 Nov; 43(7):1464-1472. PubMed ID: 28526303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Burn Center Care of Patients with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Cartotto R
    Clin Plast Surg; 2017 Jul; 44(3):583-595. PubMed ID: 28576247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stevens-Johnson syndrome and toxic epidermal necrolysis: what do we know?
    Tartarone A; Lerose R
    Ther Drug Monit; 2010 Dec; 32(6):669-72. PubMed ID: 20844465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in 87 Japanese patients--Treatment and outcome.
    Yamane Y; Matsukura S; Watanabe Y; Yamaguchi Y; Nakamura K; Kambara T; Ikezawa Z; Aihara M
    Allergol Int; 2016 Jan; 65(1):74-81. PubMed ID: 26666483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxic epidermal necrolysis and Stevens-Johnson syndrome at the Prague Burn Centre 1998-2008.
    Zajicek R; Pintar D; Broz L; Suca H; Königova R
    J Eur Acad Dermatol Venereol; 2012 May; 26(5):639-43. PubMed ID: 21668825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Fritsch PO; Sidoroff A
    Am J Clin Dermatol; 2000; 1(6):349-60. PubMed ID: 11702611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asplenic fulminant sepsis secondary to a dog bite complicated by toxic epidermal necrolysis/Stevens-Johnson syndrome.
    Teo KG; Anavekar NS; Yazdabadi A; Ricketts S
    N Z Med J; 2012 Jul; 125(1358):74-7. PubMed ID: 22864159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stevens-Johnson syndrome and toxic epidermal necrolysis-challenges of recognition and management.
    Sane SP; Bhatt AD
    J Assoc Physicians India; 2000 Oct; 48(10):999-1003. PubMed ID: 11200928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Stevens-Johnson syndrome and toxic epidermal necrolysis--updates and innovations].
    Halevy S
    Harefuah; 2010 Mar; 149(3):186-90, 193. PubMed ID: 20684173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stevens Johnson syndrome-Toxic Epidermal Necrolysis Overlap induced by sulfasalazine treatment: a case report.
    Zizi N; Elmrahi A; Dikhaye S; Fihmi N; Alami Z
    Tunis Med; 2015 Jul; 93(7):413-5. PubMed ID: 26757493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.